Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AmberHealth vs EverSlim

AmberHealth
Graded #31

Higher grade

vs+7.1000000000000085
EverSlim
Graded #54

Lower grade

The verdict

AmberHealth takes it — 82.9/100 to 75.8/100.

AmberHealth grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Round-$100 semaglutide nationwide, though tirzepatide runs $175 and it isn't verified.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAmberHealth +1
90
89
Dose & formulationAmberHealth +8
80
72
Clinical oversightAmberHealth +3
79
76
Labs & monitoringAmberHealth +25
78
53
FulfillmentEverSlim +11
86
97
Contract termsAmberHealth +27
82
55
AmberHealth · left barEverSlim · right bar

The numbers

MetricAmberHealthEverSlim
WeighScore82.9/10075.8/100
GradeB−C
Scorecard rank#31#54
Semaglutide$100/mo$127/mo
Tirzepatide$175/mo$183/mo
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
AmberHealth

Graded #31 · B−

Strengths

  • $100 semaglutide
  • All 50 states
  • Both molecules

Where it loses points

  • Not LegitScript-verified
  • Tirzepatide $175
  • Monitoring detail sparse
EverSlim

Graded #54 · C

Strengths

  • Transparent flat pricing from 127 dollars a month for compounded semaglutide; medication, provider visit, and shipping included with no insurance.
  • Names its pharmacy partners (EPIQ Scripts, Foothills, Emerald) and DrTelx medical group; LegitScript-approved and NABP-accredited.
  • Available in all 50 states and DC, with asynchronous care in 44 states and live-visit access in the rest.
  • Offers both semaglutide and tirzepatide, plus care-team messaging between visits.

Where it loses points

  • Compounded medications are not FDA-approved, and no brand-name Wegovy, Ozempic, or Zepbound options are offered.
  • Site discloses that some imagery and content may be AI-generated and some ad figures are actors, not real clinicians.
  • Newer brand with limited independent, third-party review history.

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard